Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma (Englisch)
- Neue Suche nach: Gupta, M.
- Neue Suche nach: Stenson, M.
- Neue Suche nach: O'Byrne, M.
- Neue Suche nach: Maurer, M. J.
- Neue Suche nach: Habermann, T.
- Neue Suche nach: Cerhan, J. R.
- Neue Suche nach: Weiner, G. W.
- Neue Suche nach: Witzig, T. E.
- Neue Suche nach: Gupta, M.
- Neue Suche nach: Stenson, M.
- Neue Suche nach: O'Byrne, M.
- Neue Suche nach: Maurer, M. J.
- Neue Suche nach: Habermann, T.
- Neue Suche nach: Cerhan, J. R.
- Neue Suche nach: Weiner, G. W.
- Neue Suche nach: Witzig, T. E.
In:
ANNALS OF ONCOLOGY
;
27
, 1
;
165-172
;
2016
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma
-
Beteiligte:Gupta, M. ( Autor:in ) / Stenson, M. ( Autor:in ) / O'Byrne, M. ( Autor:in ) / Maurer, M. J. ( Autor:in ) / Habermann, T. ( Autor:in ) / Cerhan, J. R. ( Autor:in ) / Weiner, G. W. ( Autor:in ) / Witzig, T. E. ( Autor:in )
-
Erschienen in:ANNALS OF ONCOLOGY ; 27, 1 ; 165-172
-
Verlag:
- Neue Suche nach: OXFORD UNIVERSITY PRESS
-
Erscheinungsdatum:01.01.2016
-
Format / Umfang:8 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.992
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.992 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 27, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
thanks to referees 2015| 2016
- 6
-
The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicineCurigliano, G. / Valagussa, P. / Veronesi, U. / Gianni, L. et al. | 2016
- 8
-
Annals of oncology in 2015: the year in reviewSoria, J. C. et al. | 2016
- 10
-
Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancerKorn, E. L. / Sachs, M. C. / McShane, L. M. et al. | 2016
- 16
-
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up†Colombo, N. / Creutzberg, C. / Amant, F. / Bosse, T. / González-Martín, A. / Ledermann, J. / Marth, C. / Nout, R. / Querleu, D. / Mirza, M. R. et al. | 2016
- 42
-
Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysisVeronese, N. / Nottegar, A. / Pea, A. / Solmi, M. / Stubbs, B. / Capelli, P. / Sergi, G. / Manzato, E. / Fassan, M. / Wood, L. D. et al. | 2016
- 49
-
Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysisRaggi, D. / Miceli, R. / Sonpavde, G. / Giannatempo, P. / Mariani, L. / Galsky, M. D. / Bellmunt, J. / Necchi, A. et al. | 2016
- 62
-
Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromesKomrokji, R. S. / List, A. F. et al. | 2016
- 68
-
Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysisLeoncini, E. / Carioli, G. / La Vecchia, C. / Boccia, S. / Rindi, G. et al. | 2016
- 81
-
Fruits, vegetables and lung cancer risk: a systematic review and meta-analysisVieira, A. R. / Abar, L. / Vingeliene, S. / Chan, D. S. / Aune, D. / Navarro-Rosenblatt, D. / Stevens, C. / Greenwood, D. / Norat, T. et al. | 2016
- 96
-
Early market access of cancer drugs in the EUMartinalbo, J. / Bowen, D. / Camarero, J. / Chapelin, M. / Démolis, P. / Foggi, P. / Jonsson, B. / Llinares, J. / Moreau, A. / O'Connor, D. et al. | 2016
- 106
-
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer†O'Shaughnessy, J. / Campone, M. / Brain, E. / Neven, P. / Hayes, D. / Bondarenko, I. / Griffin, T. W. / Martin, J. / De Porre, P. / Kheoh, T. et al. | 2016
- 114
-
Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study†Tewari, K. S. / Java, J. J. / Eskander, R. N. / Monk, B. J. / Burger, R. A. et al. | 2016
- 121
-
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)†Aparicio, T. / Lavau-Denes, S. / Phelip, J. M. / Maillard, E. / Jouve, J. L. / Gargot, D. / Gasmi, M. / Locher, C. / Adhoute, X. / Michel, P. et al. | 2016
- 127
-
Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancerKuboki, Y. / Yamashita, S. / Niwa, T. / Ushijima, T. / Nagatsuma, A. / Kuwata, T. / Yoshino, T. / Doi, T. / Ochiai, A. / Ohtsu, A. et al. | 2016
- 134
-
Prognostic factors for progression-free and overall survival in advanced biliary tract cancerBridgewater, J. / Lopes, A. / Wasan, H. / Malka, D. / Jensen, L. / Okusaka, T. / Knox, J. / Wagner, D. / Cunningham, D. / Shannon, J. et al. | 2016
- 140
-
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trialHagman, H. / Frödin, J. E. / Berglund, . / Sundberg, J. / Vestermark, L. W. / Albertsson, M. / Fernebro, E. / Johnsson, A. et al. | 2016
- 147
-
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategiesIlie, M. / Long-Mira, E. / Bence, C. / Butori, C. / Lassalle, S. / Bouhlel, L. / Fazzalari, L. / Zahaf, K. / Lalvée, S. / Washetine, K. et al. | 2016
- 154
-
A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers†Li, B. T. / Drilon, A. / Johnson, M. L. / Hsu, M. / Sima, C. S. / McGinn, C. / Sugita, H. / Kris, M. G. / Azzoli, C. G. et al. | 2016
- 159
-
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registryWagstaff, J. / Jones, R. / Hawkins, R. / Porfiri, E. / Pickering, L. / Bahl, A. / Brown, J. / Buchan, S. et al. | 2016
- 165
-
Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphomaGupta, M. / Stenson, M. / O'Byrne, M. / Maurer, M. J. / Habermann, T. / Cerhan, J. R. / Weiner, G. W. / Witzig, T. E. et al. | 2016
- 172
-
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial†Weinstein, C. / Jordan, K. / Green, S. A. / Camacho, E. / Khanani, S. / Beckford-Brathwaite, E. / Vallejos, W. / Liang, L. W. / Noga, S. J. / Rapoport, B. L. et al. | 2016
- 178
-
Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?Louis, E. / Adriaensens, P. / Guedens, W. / Vanhove, K. / Vandeurzen, K. / Darquennes, K. / Vansteenkiste, J. / Dooms, C. / de Jonge, E. / Thomeer, M. et al. | 2016
- 185
-
Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)Takeuchi, K. / Togashi, Y. / Kamihara, Y. / Fukuyama, T. / Yoshioka, H. / Inoue, A. / Katsuki, H. / Kiura, K. / Nakagawa, K. / Seto, T. et al. | 2016
- 192
-
The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC membersMaillet, D. / Blay, J. Y. / You, B. / Rachdi, A. / Gan, H. K. / Péron, J. et al. | 2016
- 199
-
A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapyGrellety, T. / Soubeyran, I. / Robert, J. / Bonnefoi, H. / Italiano, A. et al. | 2016
- 200
-
Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinibHaratani, K. / Hayashi, H. / Watanabe, S. / Kaneda, H. / Yoshida, T. / Takeda, M. / Shimizu, T. / Nakagawa, K. et al. | 2016
- 202
-
A rational approach for salvage of testicular cancer patientsSelle, F. / Soares, D. G. / Lotz, J. P. et al. | 2016
- 202
-
More on sunitinib 2 weeks on/1 week off schedule: the Rainbow analysisBasso, U. / Maruzzo, M. et al. | 2016
- 203
-
Reply to the letter to the editor ‘The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice’ by Hartmann and the letter ‘Comment on ESMO Magnitude of Clinical Benefit Scale’ by Muhonen et al.Cherny, N. I. / Sullivan, R. / Dafni, U. / Kerst, J. M. / Sobrero, A. / Zielinski, C. / de Vries, E. G. / Piccart, M. J. et al. | 2016
- 205
-
How much evidence isn't in evidence-based guidelines?Johnson, M. J. / Currow, D. C. et al. | 2016
- 206
-
Enzalutamide and sleep apnea: an emerging central nervous system side-effect?Labrize, F. / Cany, L. / Massard, C. / Loriot, Y. / Sargos, P. / Gross-Goupil, M. / Roubaud, G. et al. | 2016
- 206
-
PD-L1 copy number gain in nonsmall-cell lung cancer defines a new subset of patients for anti PD-L1 therapyGoldmann, T. / Kugler, C. / Reinmuth, N. / Vollmer, E. / Reck, M. et al. | 2016
- 208
-
Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case–Control ConsortiumWaterhouse, M. / Risch, H. A. / Bosetti, C. / Anderson, K. E. / Petersen, G. M. / Bamlet, W. R. / Cotterchio, M. / Cleary, S. P. / Ibiebele, T. I. / La Vecchia, C. et al. | 2016
- 209
-
Planning and reporting of quality-of-life outcomes in cancer trialsSchandelmaier, S. / Conen, K. / von Elm, E. / You, J. J. / Blümle, A. / Tomonaga, Y. / Saccilotto, R. / Amstutz, A. / Bengough, T. / Meerpohl, J. J. et al. | 2016